Yung Chyung

Yung Chyung serves as the Chief Medical Officer at Keros Therapeutics since November 2024, bringing extensive leadership experience from previous roles including Chief Medical Officer and EVP at Tourmaline Bio (August 2022 - October 2024) and Chief Medical Officer at Scholar Rock (February 2016 - June 2022). A background in medical research includes positions at Dyax, where roles ranged from Vice President of Medical Research to Medical Director (June 2011 - February 2016), and Global Medical Director at Genzyme (February 2010 - June 2011). Clinical training was undertaken at Massachusetts General Hospital in various capacities, including Clinician & Research Fellow in Allergy-Immunology and Internal Medicine Resident. Educational qualifications include an M.D. from Harvard Medical School and an A.B. in Biochemistry from Harvard University.